Research output

  1. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Differences in IgG autoantibody Fab glycosylation across autoimmune diseases

    Research output: Contribution to journalArticleAcademicpeer-review

View all (51) »

ID: 12360588